Patrizia Cavazzoni, leader of the Food and Drug Administration ... will take Cavazzoni’s place pending ethics clearance, FDA Commissioner Robert Califf said in an email reviewed by STAT.

The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran communicated the decision in ...

The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...

The director of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, MD, will step down from the role Jan. 18, according to an Endpoints News report. Dr. Cavazzoni joined the FDA ...

It will be co-led by Patrizia Cavazzoni, director of the FDA's Centre for Drugs Evaluation and Research (CDER), and Centre for Biologics Evaluation and Research (CBER) director Peter Marks.

“It is the FDA’s role to ensure that drugs are safe and effective,” said Patrizia Cavazzoni, director of the FDA’s center for drug evaluation and research in a November statement.

Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18. The director shared the news with staff on Friday ...

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January. Merging industry-leading business intelligence & award-winning journalism, this is an ...